With the clock ticking, scientists working with human embryonic stem cells were grappling Tuesday with how to use their remaining federal research funds before a court ruling forces them to bring their work to an abrupt end.
Recent Posts
- ‘Serial Killing’ Cell Therapy From Autolus Lands FDA Approval in Blood Cancer
- World-first stem-cell treatment restores vision in people
- Human stem cell-derived heart cells are safe in monkeys, could treat congenital heart disease
- Markers in iPSC quality control—a new approach to enhance standardization
- Nasal Spray Made From Stem Cells Could Treat Alzheimer’s Disease
- New Stem Cell Data From Space